Documented Use of Piperacillin-Tazobactam and Increased 1-Month Mortality in Healthcare-Associated Intra-Abdominal Infections
{{output}}
Background: Recent studies have increasingly questioned the efficacy and safety of piperacillin-tazobactam (TZP) in septic patients, particularly those with healthcare-associated intra-abdominal infections (hcIAI). This study ass... ...
